Literature DB >> 10411334

Hormone regulation of chondrocyte differentiation and endochondral bone formation.

D A Stevens1, G R Williams.   

Abstract

Endochondral bone formation, the formation of calcified bone on a cartilage scaffold, occurs during skeletal development, post natal growth and during bone remodelling and fracture repair. The epiphyseal growth plates represent classical tissues in which to study the ossification process, which requires two co-ordinated components; progressive chondrocyte differentiation and cartilage neovascularisation. Many gene knockout studies have produced new insights regarding how chondrocyte differentiation and angiogenesis are controlled at the molecular level. Additional genetic studies have produced new information regarding the role of hormones in the regulation of endochondral bone formation. The new challenge for the future is to determine how bone formation and turnover is physiologically regulated and co-ordinated to ensure that skeletal development and growth progresses correctly. This study reviews the emerging data in this quickly growing field which should ultimately provide fundamental insights into the normal control of endochondral ossification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411334     DOI: 10.1016/s0303-7207(99)00037-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  In vitro and in vivo endochondral bone formation models allow identification of anti-angiogenic compounds.

Authors:  Gabri van der Pluijm; Martine Deckers; Bianca Sijmons; Henny de Groot; John Bird; Ruth Wills; Socrates Papapoulos; Andy Baxter; Clemens Löwik
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  The mechanism of ascorbic acid-induced differentiation of ATDC5 chondrogenic cells.

Authors:  Tecla M Temu; Ke-Ying Wu; Philip A Gruppuso; Chanika Phornphutkul
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-08       Impact factor: 4.310

3.  Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa.

Authors:  K Johnson; S Hashimoto; M Lotz; K Pritzker; R Terkeltaub
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Morphological alterations in the growth plate cartilage of ovariectomized mice.

Authors:  Xianfeng Yao; Huayue Chen; Norihiro Ohtake; Shizuko Shoumura
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

5.  Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation.

Authors:  Sylvia C van Buul-Offers; Jeske J Smink; Ria Gresnigt; Nicole Hamers; Joost Koedam; Marcel Karperien
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

6.  SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation.

Authors:  Michele R Hutchison; Mary H Bassett; Perrin C White
Journal:  Mol Endocrinol       Date:  2009-11-06

Review 7.  The role of estrogen receptor α in the regulation of bone and growth plate cartilage.

Authors:  A E Börjesson; M K Lagerquist; S H Windahl; C Ohlsson
Journal:  Cell Mol Life Sci       Date:  2013-03-21       Impact factor: 9.261

8.  Comparative study of the effects of different growth hormone doses on growth and spatial performance of hypophysectomized rats.

Authors:  Min Jung Kwak; Hee-Ju Park; Mi Hyun Nam; O Suk Kwon; So Young Park; So Yeon Lee; Mi Jin Kim; Su Jin Kim; Kyung Hoon Paik; Dong-Kyu Jin
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

9.  Spongiosa primary development: a biochemical hypothesis by Turing patterns formations.

Authors:  Oscar Rodrigo López-Vaca; Diego Alexander Garzón-Alvarado
Journal:  Comput Math Methods Med       Date:  2012-09-12       Impact factor: 2.238

10.  Vitamin e and bone structural changes: an evidence-based review.

Authors:  Isa Naina Mohamed; Boekhtiar Borhanuddin; Ahmad Nazrun Shuid; Nur Farhana Mohd Fozi
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.